was depleted of lymphocytes with receptors for sheep red blood cell-antibody-complement complexes [EAC-(±) ]. Analysis of these populations showed that ADCC effector activity was predominantly a property of the Ig(-) lymphocytes which are E(-) but EAC(+).
These lymphocytes have been referred to as "null lm- phocytes" anid probably represent a subset of bolne marrow-derived (B) cells. In addition, val-iable and lowv levels of ADCC activity were observed in somiie Ig(+) populations (B cells). Further purification of the null cell population by filtration over nylon wool coluimIns to reduce the number of contaminating latex ingesting monocytes did not reduce ADCC effector activity.
Isolated null cell ADCC effector activity was inhibited by either rabbit anti-human F(ab)2 or normal pooled
Reccized for publication 2 (6) (7) (8) (9) . Several studies have showvn that the effector cell in ADCC is a non-T cell and does not require prior sensitization (10) (11) (12) (13) . Attempts to identify the effector population within the non-T cell populations have yielded seemingly conflicting results. van Boxel et al. (10) , using anti-O antisera, suggested the possibility that the effector cell is a bone marrow-derived (B) cell or a subpopulationi of B cells. Consistent with this theory, both Perlmann et al. (9) and Schirrmacher et al. (11) reported that the effector cells from mouse spleens are absorbed onto anti-immunoglobulin columns. Subsequently, Perlmann et al. (14) reported that mature B cells with a high concentration of surface immunoglobulin were inactive as ADCC effector cells. In contrast, Greenberg et al. (12) , using Sephadex anti-immunoglobulin columns, found that the effector cells remained in the effluent and were not absorbed onto the anti-immunoglobulin columns. They further proposed, oni the basis of sedimenitation studies, that the effector cell is a nonphagocytic monocvte. Wisloff and Froland (13) , using nylon wool columns with human ly)mphocytes, also noted that effector cell activity increased after B cell depletion and concluded that ADCC in man is independent of B cells.
To further study this problem of the nature of the ADCC effector cell in circulating human peripheral lymphocytes, we have utilized a series of cell separation techniques recently reported from this laboratory (15) (16) (17) . When applied to human peripheral lymphocytes, these techniques allow for the preparation of relatively pure subpopulations of Ig(-), E(+), EAC(-), T cells; Ig(+), E(-), EAC (16) . To prepare a population of Ig(-), E(-) cells, the Ig(-) lymphocytes obtained after column separation were depleted of sheep RBC rosette-forming [E(+)] lymphocytes. After Ficoll-Hypaque centrifugation, the isolated Ig(-), E(-) cell population w-as washed thrce times andl brought to a concentration of 2 X 106 cells/ml. This population which was termed the "null cell population," contained less than 2% Ig(+) cells, less than 4% E(+) cells, and varied between 50 and 90% EAC(+).
To prepare a population of Ig(-), E(+) cells, the Ig(-) effluent cells obtained after column fractionation were depleted of EAC rosetting cells in a similar manner, and the remaining cells were washed three times and brought to 2 X 106 cells/ml. This cell population was less than 2% Ig(+), less than 2% EAC(+), and 80-95% E(+) and was designated the "T cell population." With both the E and EAC rosette depletion techniques, total cell recovery was between 50 and 70%. In some experiments latex-ingesting mononuclear cells were removed by passage over a nylon wool column as previously described (5).
Antti-humiiiant lymiiphocyte antiserum. Adult rabbits were injected intravenously with 3 X 106 Ficoll-purified human lymphocytes on three occasions, 1 wk apart. The serum was harvested at 4 wk, heat-inactivated at 56°C for 30 min, and stored at -30°C.
Target cells. Autologous Ficoll-purified mononuclear cells, isolated as above, were also used as target cells. 1.5 X 107 cells were labeled with 0.15 ml of Na2mCrO4 (292 mCi/mg) (New England Nuclear, Boston), for 30 min at 370C with slow continued inversion. The antibody-labeled target cells and control cells were further washed twice more to remove excess unbound antibody and brought to a final concentration of 105 cells/ml. ADCC assay. Into 10 x 75-mm tubes, 0.1 ml of 51Cr-labeled target cells at 105 cells/ml was pipetted in triplicate. 0.2 ml of the appropriate suspension of killer cells was added, and the tubes were centrifuged at 1,000 g for 10 min and incubated at 37°C in 5% C02 overnight. After 16 h incubation, 1.7 ml of fresh media was added to each tube, the tubes centrifuged at 1,000 g for 10 min, and 1 ml of supernate was removed and assayed for 'y radiation. Maximal 'Cr release was determined by alternate freezing and thawing of target cells. Percent cytotoxicity was determined by the formula: percent cytotoxicity = [5Cr released by experimental -5Cr released from control (spontaneous)]/ [5'Cr released by freeze-thaw -Cr released from control], and results were expressed as percent cytotoxicity±SEM.
Anzti-humiiian Fab imnizunoglobutlini. Rabbit antibody against human immunoglobulin F(ab)2 and rabbit F(ab)2 antihuman F(ab)2 were prepared as described (15 Effect of nylon wool filtration. To determine whether ADCC activity was due to the monocyte population, the isolated null-monocyte preparation was depleted of nylon wool-adherent monocytes by passage over a nylon wool column. The activity of the nonadherent null cells, after passage through the nylon wool, was compared to the activity of the same population of null cells and monocytes before nylon wool filtration. After filtration, the percent of monocytes was reduced to less than 1% latexingesting cells. Despite this marked depletion of phagocytic cells, there was no effect, or possibly even enhancement, on the ADCC activity (Fig. 2) . Thus, as demonstrated by this sequence of experiments ADCC activity parallels the content of Ig(-), E(-), nonphagocytic cells or null cells. Inhibition of effector cells. Prior studies on mouse spleen ADCC effector cells have noted that these cells have a surface receptor for the Fc portion of IgG antibody, and if this receptor is blocked, ADCC activity is inhibited (1, 9, 12) . To see if a similar mechanism was present in the autologous human system, the following experiment was performed: column effluent cells, from which the Ig(+) cells had been removed, were divided into four aliquots and incubated with equivalent concentrations of rabbit anti-human F(ab)2, rabbit F(ab)2 anti-human F (ab)2, normal pooled rabbit gamma globulin, and media. After a 30-min incubation, the effector cells were washed three times and assayed for ADCC After nylon wool filtration, the percent of latex-ingesting monocytes was reduced from 10% to less than 1%. Cells from each population were incubated with autologous unfractionated 51Cr-labeled, antibody-sensitized target cells for 16 h. The freeze-thaw value in this experiment was 373±51
and the spontaneous release 106±+15.
activity. As seen in Table III, incubation with either whole rabbit anti-human F(ab)2 or pooled rabbit gamma globulin markedly inhibited the effector cells, while a similar concentration of rabbit F(ab)2 anti-human F(ab)2 had minimal effect. Thus, as in the mouse system, inhibition was dependent upon the presence of the Fc portion of the immunoglobulin molecule. This supports the concept that this population of Ig (-), E (-), effector cells is also characterized by an Fc surface receptor and furthermore, that this receptor plays a critical role in ADCC function. DISCUSSION Recent advances in the ability to isolate subpopulations of human peripheral blood lymphocytes has facilitated our understanding of their unique functions. The ability to make definitive interpretations, of course, depends in part upon the homogeneity of the isolated cell populations and the amount of cell loss during the isolation procedure. In the present studies we have isolated three subpopulations of human lymphocytes which are readily distinguished by surface characteristics: an Ig(-), E(-), EAC(+) (null cell) population; an Ig(+), E(-), EAC(+) (B cell) population; and an Ig(-), E(+), EAC(-) (T cell) population. Using these subpopulations, we have analyzed the problem of which If such cells were present in vivo in periplheral blood, they would probably segregate with the whole B cell population during our fractionation precedures. Hence, the variability of B cell killing previously described may really be a reflection of the percentage of these cells which are circulating in any donor at the time of phlebotomy. Further studies of null cell-B cell relationships are in progress. For the present, to avoid semantic arguments, it seems fair to conclude that ADCC effector activity in human peripheral blood lymphocytes is a property of null cells and their progeny. The importance of the circulating monocyte is unclear, but in view of this and prior work (13, 21) in which depletion of monocytes enhanced the ADCC activity of the residual population, it appears that circulating monocytes play a minor role in vitro with regard to this immunologic function.
ADCC killing of target cells has now been demonstrated against xenogeneic red cells (9), cultured tumor cell lines (22) , allogeneic myeloblasts (23), virus-infected cells (24, 25) , allogenic (26) , and now autologous lymphocytes. In addition, recent studies have also shown that patients with transitional cell carcinoma (TCC) can develop antibody which specifically renders cultured TCC cell lines susceptible to ADCC killing by patient lymphocytes (27, 28) . Thus, evidence is mounting that ADCC is an ubiquitous immune cytotoxic mechanism, at least in vitro. Additionally, it has been noted that in certain disease states, such as immunodeficiency syndromes, autoimmune disorders, and neoplasms, the percentage of null cells in the peripheral blood is elevated (29) . The emerging concept of these null cells as major effectors in ADCC suggests the possibility that null cells, perhaps through their ADCC function, play an important pathophysiologic role in these diseases. These speculations, as well as the biological significance of null cells and ADCC, require further study.
